Stereotaxis (STXS)
(Delayed Data from AMEX)
$2.22 USD
-0.05 (-2.20%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $2.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Stereotaxis Inc. has a market cap of $195.22M, which represents its share price of $2.27 multiplied by its outstanding shares number of 86.00M. As a small-cap company, STXS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
STXS 2.22 -0.05(-2.20%)
Will STXS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for STXS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for STXS
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know
Teleflex (TFX) Q2 Earnings and Revenues Top Estimates
STXS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial
Stereotaxis Inc. (STXS) Reports Q1 Loss, Tops Revenue Estimates
AxoGen (AXGN) Reports Q1 Loss, Tops Revenue Estimates
Other News for STXS
Stereotaxis (STXS) Secures FDA Clearance for Innovative Catheter
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter | STXS Stock News
Stereotaxis receives FDA clearance for MAGiC Sweep catheter
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025 | STXS Stock News
Stereotaxis (STXS) Raises $12.5 Million in Direct Offering